Publications

Highlights of relevant published scholarly research work by our Nanomedicine COE-TCR members (indexed by year, since inception):

(2017)

1. D. Guzman-Villanueva, R. Q. Migrino, S. Truran, N. Karamanova, D. A. Franco, P. Hari,  V. Weissig.  PEGylated-Nanoliposomal Clusterin for Amyloidogenic Light Chain-Induced Endothelial Dysfunction.  J Liposome Res 2017, Jan 20:1-23. doi: 10.1080/08982104.2016.1274756. PubMed  [citation] PMID :28103719 
2. Rogers NM, Sharifi-Sanjani M,  Yao M, Ghimire K, Bienes-Martinez R, Mutchler SM, Knupp HE, Baust J, Novelli EM, Ross M, St Croix C, Kutten JC, Czajka CA, Sembrat JC, Rojas M, Labrousse-Arias D, Bachman TN, Vanderpool RR, Zuckerbraun BS, Champion HC, Mora AL, Straub AC, Bilonick RA, Calzada MJ, Isenberg JS . TSP1-CD47 Signaling is Upregulated in Clinical Pulmonary Hypertension and Contributes to Pulmonary Arterial Vasculopathy and Dysfunction.  Cardiovas Res (2017) Jan. 113: 15-29. doi: 10.1093/cvr/cvw218. PubMed  [citation] PMID:27742621
   
3. Weissig V . Liposomes came first.  Methods Mol Biol. 2017;1522:1-15 doi:10.1007/978-1-4939-6591-5_1. PubMed   [citation] PMID:27837526
4. Joshi M, Park G, Pichlik J, Patel K. and Patel R. (2017) In vitro evaluation of bortezomib encapsulated in cationic and C6-ceramide liposomes, J Pharma Sci Pharmacol, 3, 1-9.

(2016)

1. Steuber N, Vo K, Wadhwa R, Birch J, Iacoban P, Chavez P,  Elbayoumi  TA .  Tocotrienol Nanoemulsion Platform of Curcumin Elicit Elevated Apoptosis and Augmentation of Anticancer Efficacy against Breast and Ovarian Carcinomas.  Int J Mol Sci. 2016 Oct;17(11):E1792. doi: 10.3390/ijms17111792. PubMed  [citation] PMID:27792193
2. Shen R, Kim JJ,  Yao M,  Elbayoumi  TA .  Development and evaluation of vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical.  Int J Nanomedicine. 2016 Apr 26;11:1687-700. doi: 10.2147/IJN.S103332. eCollection 2016. PubMed  [citation] PMID: 27217747
3. Pham J, Nayel A, Hoang C,  Elbayoumi  TA .  Enhanced effectiveness of tocotrienol-based nano-emulsified system for topical delivery against skin carcinomas.  Drug Deliv. 2016 Jun;23(5):1514-24. doi: 10.3109/10717544.2014.966925. PubMed  [citation] PMID: 25293973
4. Elbayoumi TA. Editorial: Lipidic Nano-carrier Delivery of "Big" Molecules.  Curr Pharm Biotechnol.2016;17(8):661. PubMed  [citation] PMID: 27215370
5. Hull EE, Montgomery MR, Leyva KJ. HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases.  Biomed Res Int.2016;2016:8797206. doi: 10.1155/2016/8797206. PubMed  [citation] PMID: 27556043
6. Davis MR, Daggett JJ, Pascual AS, Lam JM, Leyva KJ, Cooper KE,  Hull EE. Epigenetically maintained SW13+ and SW13- subtypes have different oncogenic potential and convert with HDAC1 inhibition.  BMC Cancer. 2016 May 17;16:316. doi: 10.1186/s12885-016-2353-7. PubMed  [citation] PMID: 27188282
7. Joshi M, Oesterling B., Wu C., Gwizdz N., Pais G., Briyal S. and Gulati A. (2016) Evaluation of liposomal nanocarriers loaded with ETB receptor agonist, IRL-1620, using cell based assays,  Neuroscience. 312, 141-152.
8. Joshi M (2016) Interviewed for "Life Science Avenues and Opportunities" (LSAO), A complete guide to step up the life science career ladder in the Inspiring Role Models in the Life Sciences Sector.
9. Joshi M, (2016) Nanomedicines for treatment of stroke-Opinion Article,  Int J Nanomed Nanosurgery. 2(3).
10. Yao M, Sturdivant J,  Elbayoumi  TA .  Novel Pharmaceutical Strategy for Selective Abrogation of Thrombospondin 1-Induced Vascular Dysfunctions via Decoy recombinant CD47.  The FASEB J.2016 April;30(1):Supl.1201.3
11. Rogers NM, Sharifi-Sanjani M , Yao M, Ghimire K, Bienes-Martinez R, et al. TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction.  Cardiovasc Res. 2016 Oct;23(5):1514-24. doi:10.1093/cvr/cvw218. PubMed  [citation] PMID: 27742621
12. Valekunja RB, Kamakoti V, Peter A, Phadnis A, Prasad S, and  Nagaraj VJ. The Detection of Papaya Ringspot Virus Coat Protein Using an Electrochemical Immunosensor.  Anal Methods. 2016 ( in press)
13. J.P. Hegarty, J. Krzeminski, A.K. Sharma, D. Guzman-Villanueva,  V. Weissig, D.B. Stewart. Bolaamphiphile-based Nanocomplex Delivery of Phosphorothioate Gapmer Antisense Oligonucleotides as a Treatment for Clostridium difficile.  Int J Nanomedicine. 2016:11, 3607-3619. doi: 10.2147/IJN.S109600. PubMed  [citation] PMID:27536102
14. Franco, D.A., Truran, S.,  Weissig, V., Guzman-Villanueva, D., Senapati, S., Karamanova, N. Burciu, C., Ramirez-Alvarado, M., Lindsay, S., Hari, P., and Migrino, R.Q. Monosialoganglioside-containing Nanoliposomes restore endothelial function impaired by AL Amyloid Light Chain Proteins.  J Am Heart Assoc. 2016 Aug 1;11:3607-19 doi: 10.1161/JAHA.116.003318. PubMed  [citation] PMID:27412900
15. S. Truran,  V. Weissig, J. Madine, H. Davies, D. Guzman-Villanueva, D. A. Franco, C. Burciu, N. Karamanova, Serrano, G., Beach, T.G., R. Q. Migrino. Nanoliposomes Protect against Human Arteriole Endothelial Dysfunction Induced by β-amyloid Peptide,  J Cerebral Blood Flow & Metabolism. 2016 Feb;36(2):405-12. doi:10.1177/0271678X15610134. PubMed  [citation] PMID: 26661197

1. A. Prokop,  V. Weissig (Editors): Intracellular Delivery III, Fundamentals and Applications. ( 2017) Springer, Dordrecht, Heidelberg, New York, London.  [Link]
2. V. Weissig, M. Edeas (Editors): Mitochondrial Medicine: Methods and Protocols. Volume 1: Probing mitochondrial function. ( 2015) Springer Protocol Series "Methods in Molecular Biology", The Humana Press Inc., Totowa, NJ, USA.  [Link]
3. V. Weissig, M. Edeas (Editors): Mitochondrial Medicine: Methods and Protocols. Volume 2: Manipulating mitochondrial function. ( 2015) Springer Protocol Series "Methods in Molecular Biology", The Humana Press Inc., Totowa, NJ, USA.  [Link]
4. V. Weissig, T. Elbayoumi, M Olsen (Editors): Cellular and Subcellular Nanotechnology: Methods and Protocols. Springer Protocol Series "Methods in Molecular Biology", MiMB Series No 991 ( 2013). 32 chapters, 370 pages, The Humana Press Inc., Totowa, NJ, USA.  [Link]
5. V. Weissig and G. GM D'Souza (Editors): Organelle-specific Pharmaceutical Nanotechnology ( 2010). 27 chapters, 590 pages. John Wiley & Sons, Inc., New York.  [Link]
6. V. Weissig (Editor): Liposomes. Methods and Protocols. Volume 1: Pharmaceutical Nanocarriers. Springer Protocol Series "Methods in Molecular Biology", Volume 605" ( 2010). 36 chapters, 563 pages. The Humana Press Inc., Totowa, NJ, USA.  [Link]
7. V. Weissig (Editor): Liposomes. Methods and Protocols. Volume 2: Biological Membrane Models. Springer Protocol Series "Methods in Molecular Biology", Volume 606" ( 2010). 36 chapters, 548 pages. The Humana Press Inc., Totowa, NJ, USA.  [Link]